http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S6122071-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a98cb1b197f761c87cd3caf32bc247e2
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C279-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D231-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C67-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C239-00
filingDate 1985-04-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_071a19c9ddcb6951eabe5ea1282cb6b6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f535b1ec7662fbf205df2708a9356bc5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_70d9145c1e5757752252034c757e70d6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_422d72587637a11f17efff95ee63fa9b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d1ee33a8c287018fefad8a15071f09d8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3dff79edd5d0fc0adc32d2ee50f5d45b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3c256c1fbb62a2059f4a11eea5852fe2
publicationDate 1986-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-S6122071-A
titleOfInvention Biguanide derivative 5-membered ring heterocyclic carboxylic acid salt and its preparation
abstract NEW MATERIAL:A salt of biguanide derivative 5-membered ring heterocyclic carboxylate of formula I (one or R 1 and R 2 is H, lower alkyl aralkyl, the other is lower alkyl, aralkyl). n EXAMPLE: 1,1-Dimethylbiguanide 3-methylpyrazole-5-carboxylate. n USE: It is used as a remedy for diabetes, since it has action to reduction of blood sugar and free fatty acids. It is advantageous that the efficacy is not decreased, even after it has been continuously administered and is low in toxicity. n PREPARATION: Preferably, equimolar amounts of a compound of formula IIsuch as dimethylbiguanide and another compound of formula III (e.g., 3-methylpyrazole-5-carboxylic acid) are used to effect their reaction in a solvent such as methanol or acetone at room temperature to 100°C to give a compound of formula I. The compound of formula I is isolated by the isolation process such as distillation or chromatography. n COPYRIGHT: (C)1986,JPO&Japio
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0204118-A1
priorityDate 1985-04-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414866135
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411932836
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419537701
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419497074
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13671356
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID180
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9822
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4091
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID236073761
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID887

Total number of triples: 34.